ask="3.2000"
ask_size="500"
average_daily_volume="117931"
bid="2.3500"
bid_size="1000"
book_value="1.3590"
change="+0.0028"
change_from_200_day_moving_average="-0.1747"
change_from_50_day_moving_average="0.1346"
change_from_52_week_high="-5.4872"
change_From_52_week_low="0.5728"
change_in_percent="+0.1045%"
close="2.6828"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.2860"
ebitda="-12.73M"
eps_estimate_current_year="-5.9100"
eps_estimate_next_quarter="-1.0500"
eps_estimate_next_year="-3.3000"
ex_dividend_date="N/A"
float_shares="4194000"
high="2.7000"
high_52_weeks="8.1700"
last_trade_date="2/8/2017"
last_trade_price="2.6828"
last_trade_size="200"
last_trade_time="3:58pm"
low="2.6210"
low_52_weeks="2.1100"
market_capitalization="18.13M"
moving_average_200_day="2.8575"
moving_average_50_day="2.5482"
name="Onconova Therapeutics
Inc."
notes="N/A"
one_year_target_price="6.0000"
open="2.6800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-6.1144%"
percent_change_from_50_day_moving_average="+5.2830%"
percent_change_from_52_week_high="-67.1628%"
percent_change_from_52_week_low="+27.1469%"
previous_close="2.6800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.9720"
price_per_sales="1.2100"
revenue="14.97M"
shares_outstanding="6759000"
short_ratio="1.9100"
stock_exchange="NCM"
symbol="ONTX"
volume="25592"
weeks_range_52="2.1100 - 8.1700"
